193 related articles for article (PubMed ID: 33276641)
1. 3D Printed Tacrolimus Rectal Formulations Ameliorate Colitis in an Experimental Animal Model of Inflammatory Bowel Disease.
Seoane-Viaño I; Gómez-Lado N; Lázare-Iglesias H; García-Otero X; Antúnez-López JR; Ruibal Á; Varela-Correa JJ; Aguiar P; Basit AW; Otero-Espinar FJ; González-Barcia M; Goyanes A; Luzardo-Álvarez A; Fernández-Ferreiro A
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33276641
[TBL] [Abstract][Full Text] [Related]
2. 3D printed tacrolimus suppositories for the treatment of ulcerative colitis.
Seoane-Viaño I; Ong JJ; Luzardo-Álvarez A; González-Barcia M; Basit AW; Otero-Espinar FJ; Goyanes A
Asian J Pharm Sci; 2021 Jan; 16(1):110-119. PubMed ID: 33613734
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the therapeutic activity of melatonin and resveratrol in Inflammatory Bowel Disease: A longitudinal PET/CT study in an animal model.
Seoane-Viaño I; Gómez-Lado N; Lázare-Iglesias H; Rey-Bretal D; Lamela-Gómez I; Otero-Espinar FJ; Blanco-Méndez J; Antúnez-López JR; Pombo-Pasín M; Aguiar P; Ruibal Á; Luzardo-Álvarez A; Fernández-Ferreiro A
Int J Pharm; 2019 Dec; 572():118713. PubMed ID: 31593809
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal PET/CT evaluation of TNBS-induced inflammatory bowel disease rat model.
Seoane-Viaño I; Gómez-Lado N; Lázare-Iglesias H; Barreiro-de Acosta M; Silva-Rodríguez J; Luzardo-Álvarez A; Herranz M; Otero-Espinar F; Antúnez-López JR; Lamas MJ; Aguiar P; Fernández-Ferreiro A; Ruibal Á
Int J Pharm; 2018 Oct; 549(1-2):335-342. PubMed ID: 30081226
[TBL] [Abstract][Full Text] [Related]
5. 3D printed multi-drug-loaded suppositories for acute severe ulcerative colitis.
Awad A; Hollis E; Goyanes A; Orlu M; Gaisford S; Basit AW
Int J Pharm X; 2023 Dec; 5():100165. PubMed ID: 36876053
[TBL] [Abstract][Full Text] [Related]
6. 3D printed infliximab suppositories for rectal biologic delivery.
Awad A; Goyanes A; Orlu M; Gaisford S; Basit AW
Int J Pharm X; 2023 Dec; 5():100176. PubMed ID: 37396625
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus (FK506) for induction of remission in corticosteroid-refractory ulcerative colitis.
Gordon M; Sinopoulou V; Akobeng AK; Pana M; Gasiea R; Moran GW
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD007216. PubMed ID: 35388476
[TBL] [Abstract][Full Text] [Related]
8. 3D-printed prednisolone phosphate suppositories with tunable dose and rapid release for the treatment of inflammatory bowel disease.
Kocabas LI; Ayyoubi S; Tajqurishi M; Quodbach J; Vermonden T; Kok RJ
Int J Pharm; 2024 Jan; 649():123639. PubMed ID: 38042381
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Study in Vivo for New Pharmacological Approaches in Inflammatory Bowel Disease: A Systematic Review of Chronic Model of TNBS-Induced Colitis.
Silva I; Pinto R; Mateus V
J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31581545
[TBL] [Abstract][Full Text] [Related]
10. Mesalazine hollow suppositories based on 3D printing for treatment of ulcerative colitis.
Wei M; Liu D; Sun Y; Xie H; Du L; Jin Y
Int J Pharm; 2023 Jul; 642():123196. PubMed ID: 37399930
[TBL] [Abstract][Full Text] [Related]
11. Imaging of intestinal lymphocyte homing by means of pinhole SPECT in a TNBS colitis mouse model.
Bennink RJ; van Montfrans C; de Jonge WJ; de Bruin K; van Deventer SJ; te Velde AA
Nucl Med Biol; 2004 Jan; 31(1):93-101. PubMed ID: 14741574
[TBL] [Abstract][Full Text] [Related]
12. Copaifera malmei Harms leaves infusion attenuates TNBS-ulcerative colitis through modulation of cytokines, oxidative stress and mucus in experimental rats.
Pavan E; Damazo AS; Arunachalam K; Almeida POA; Oliveira DM; Venturini CL; Figueiredo FF; Cruz TCDD; Silva JVD; Martins DTO
J Ethnopharmacol; 2021 Mar; 267():113499. PubMed ID: 33091486
[TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
14. Colon-Targeted Therapy of Tacrolimus (FK506) in the Treatment of Experimentally Induced Colitis.
Ali AS; Altayari AA; Khan LM; Alharthi SE; Ahmed OA; El-Shitany NA; Ali SS; Saadah OI
Pharmacology; 2020; 105(9-10):541-549. PubMed ID: 31940656
[TBL] [Abstract][Full Text] [Related]
15. A Proof of Concept for 3D Printing of Solid Lipid-Based Formulations of Poorly Water-Soluble Drugs to Control Formulation Dispersion Kinetics.
Vithani K; Goyanes A; Jannin V; Basit AW; Gaisford S; Boyd BJ
Pharm Res; 2019 May; 36(7):102. PubMed ID: 31098846
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effect of Chang-An-Shuan on TNBS-induced experimental colitis in rats.
Mi H; Liu FB; Li HW; Hou JT; Li PW
BMC Complement Altern Med; 2017 Jun; 17(1):315. PubMed ID: 28619075
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus Suppositories in Therapy-Resistant Ulcerative Proctitis.
Jaeger SU; Klag T; Hoeger K; Klumpp S; Escher M; Malek N; Stange E; Wehkamp J
Inflamm Intest Dis; 2019 Feb; 3(3):116-124. PubMed ID: 30820433
[TBL] [Abstract][Full Text] [Related]
18. Intestinal anti-inflammatory activity of the seeds of Raphanus sativus L. in experimental ulcerative colitis models.
Choi KC; Cho SW; Kook SH; Chun SR; Bhattarai G; Poudel SB; Kim MK; Lee KY; Lee JC
J Ethnopharmacol; 2016 Feb; 179():55-65. PubMed ID: 26721217
[TBL] [Abstract][Full Text] [Related]
19. Elucidation of colon-protective efficacy of diosgenin in experimental TNBS-induced colitis: inhibition of NF-κB/IkB-α and Bax/Caspase-1 signaling pathways.
Tang X; Huang G; Zhang T; Li S
Biosci Biotechnol Biochem; 2020 Sep; 84(9):1903-1912. PubMed ID: 32525764
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of rectal administration of muscovite on experimental colitis in rats.
Chen Y; Chen Y; Liu WL; Zhou TH; Cai JT; Du Q; Wang LJ; Wu JG; Si JM
J Gastroenterol Hepatol; 2009 May; 24(5):912-9. PubMed ID: 19220658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
